Skip to main content

Table 3 Multivariate COX regression analysis: Patient survival was analysed by multivariate COX regression analysis

From: Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer

  

95% CI

 

Covariate

Coefficient (bi)

[HR Exp(bi)]

Lower

Upper

P-value

FIGO stage

    

<0.001

I

(0.000)

(1.00)

   

II

−3.064

.047

.011

.192

<0.001

III

−3.025

.049

.010

.233

<0.001

IV

−1.810

.164

.040

.669

.012

WHO grade

    

.023

1

(0.000)

(1.00)

   

2

−.820

.440

.246

.790

.006

3

−.561

.571

.325

1.002

.051

Histology

    

0.068

Endometrioid

(0.000)

(1.00)

   

Serous

−.297

.743

.233

2.372

.616

Clear cell

−.069

.934

.260

3.349

.916

Mucinous

−1.423

.241

.024

2.403

.225

Squamous cell

.074

1.077

.260

4.470

.918

Mixed cell

3.167

23.742

2.245

251.079

.008

Undifferentiated

−.163

.850

.255

2.828

.790

Lymph node metastasis

−.732

.481

.209

1.109

.086

Age (≤50 y vs. >50 y)

1.939

6.953

.909

53.204

.062

Diabetes

.451

1.570

.880

2.800

.127

Obesity

−.065

.937

.600

1.462

.774

Hypertension

.454

1.575

1.043

2.380

.031

Lymphangiosis

.216

1.241

.631

2.443

.532

Hemangiosis

.681

1.975

.476

8.187

.348

ER alpha

−.031

.970

.652

1.442

.880

PRA

−.156

.855

.572

1.279

.446

GdA

.840

2.317

1.362

3.943

.002

Gd

−.298

.743

.456

1.209

.232

  1. Significant results are shown in bold.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us